Home
Dashboard
Curated content

Startups & Scaleups
Corporates
Investors
Funding rounds
Exits

Accelerators
Workspaces
Universities
Service providers
More organizations

Matching tool
Investment heatmap
Themes

News

Powered by

dealroom.co

Contact
FAQ
Privacy

Companies
ImmunityBio
Team
Team

ImmunityBio

ImmunityBio pioneers innovative therapies to conquer disease through immune system reprogramming. Learn more

Launch date

2014

Employees

501-1000 people

Market cap

€2.2b

Enterprise valuation

€2.7b (Public information from Sep 2024)

Share price

$3.48 IBRX

Culver City California (HQ)

http://immunitybio.com

https://twitter.com/nantworks https://www.facebook.com/immunitybio1 https://www.linkedin.com/company/immunitybio/

B2B
manufacturing
subscription
health
biotechnology

hard tech
biotechnology
biotech and pharma
immune system
immunotherapy

Authorizing premium user...